MicroRNAs (miRNAs) are small RNAs that participate in the regulation of genes associated with the differentiation and proliferation. In this study, 5 novel miRNAs were identified from human mesenchymal stem cells and characterized using various analyses. To investigate the potential functions associated with the regulation of cell differentiation, the differences in miRNA expression were examined in undifferentiated and differentiated human embryonic stem (ES) cells using reverse transcription (RT)-PCR analysis. Specifically, 3 miRNAs exhibited decreased expression levels in human umbilical vein endothelial cells (HUVECs) and endothelial cells derived from human ES cells. Putative target genes related to differentiation or maturation of endothelial cells were predicted by seed sequences of 2 novel miRNAs and analyzed for their expression via miRNA-mediated regulation using a luciferase assay. In HUVECs, CDH5 gene expression was directly repressed by hsa-miR-6086. Similarly, hsa-miR-6087 significantly downregulated endoglin expression. Therefore, the roles of these 2 miRNAs may be to directly suppress their target genes, popularly known as endothelial cell markers. Taken together, our results demonstrate that several novel miRNAs perform critical roles in human endothelial cell development.
Get full access to this article
View all access options for this article.
References
1.
LaurentLC, ChenJ, UlitskyI, MuellerFJ, LuC, ShamirR, FanJB, LoringJF. 2008. Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells, 26:1506–1516.
2.
CalinGA, DumitruCD, ShimizuM, BichiR, ZupoS, NochE, AldlerH, RattanS, KeatingMet al.2002. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 99:15524–15529.
3.
ToliaNH, Joshua-TorL. 2007. Slicer and the argonautes. Nat Chem Biol, 3:36–43.
4.
GrishokA, PasquinelliAE, ConteD, LiN, ParrishS, HaI, BaillieDL, FireA, RuvkunG, MelloCC. 2001. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell, 106:23–34.
5.
NelsonKM, WeissGJ. 2008. MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther, 7:3655–3660.
6.
Lagos-QuintanaM, RauhutR, YalcinA, MeyerJ, LendeckelW, TuschlT. 2002. Identification of tissue-specific microRNAs from mouse. Curr Biol, 12:735–739.
7.
ZengY, CullenBR. 2003. Sequence requirements for micro RNA processing and function in human cells. RNA, 9:112–123.
8.
WienholdsE, PlasterkRH. 2005. MicroRNA function in animal development. FEBS Lett, 579:5911–5922.
9.
StarkA, KheradpourP, PartsL, BrenneckeJ, HodgesE, HannonGJ, KellisM. 2007. Systematic discovery and characterization of fly microRNAs using 12 Drosophila genomes. Genome Res, 17:1865–1879.
10.
HuangKM, DentchevT, StambolianD. 2008. MiRNA expression in the eye. Mamm Genome, 19:510–516.
HatfieldSD, ShcherbataHR, FischerKA, NakaharaK, CarthewRW, Ruohola-BakerH. 2005. Stem cell division is regulated by the microRNA pathway. Nature, 435:974–978.
14.
CalabreseJM, SeilaAC, YeoGW, SharpPA. 2007. RNA sequence analysis defines Dicer's role in mouse embryonic stem cells. Proc Natl Acad Sci U S A, 104:18097–18102.
15.
ChoSW, MoonSH, LeeSH, KangSW, KimJ, LimJM, KimHS, KimBS, ChungHM. 2007. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation, 116:2409–2419.
16.
ChenC, RidzonD, LeeCT, BlakeJ, SunY, StraussWM. 2007. Defining embryonic stem cell identity using differentiation-related microRNAs and their potential targets. Mamm Genome, 18:316–327.
17.
KanellopoulouC, MuljoSA, KungAL, GanesanS, DrapkinR, JenuweinT, LivingstonDM, RajewskyK. 2005. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev, 19:489–501.
18.
AhnSE, KimS, ParkKH, MoonSH, LeeHJ, KimGJ, LeeYJ, ChaKY, ChungHM. 2006. Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem Biophys Res Commun, 340:403–408.
19.
AhnJS, MoonSH, KimJ, ChungHM, KimJK. 2010. Identification of differentially expressed genes in human embryonic stem cell-derived endothelial cells using suppression subtractive hybridization. Stem Cells Dev, 19:1249–1256.
RenJ, JinP, WangE, MarincolaFM, StroncekDF. 2009. MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med, 7:20.
22.
RoS, ParkC, JinJ, SandersKM, YanW. 2006. A PCR-based method for detection and quantification of small RNAs. Biochem Biophys Res Commun, 351:756–763.
23.
Lagos-QuintanaM, RauhutR, LendeckelW, TuschlT. 2001. Identification of novel genes coding for small expressed RNAs. Science, 294:853–858.
KimJ, MoonSH, LeeSH, LeeDR, KohGY, ChungHM. 2007. Effective isolation and culture of endothelial cells in embryoid body differentiated from human embryonic stem cells. Stem Cells Dev, 16:269–280.
27.
AfanasyevaEA, Hotz-WagenblattA, GlattingKH, WestermannF. 2008. New miRNAs cloned from neuroblastoma. BMC Genomics, 9:52.
28.
TijstermanM, PlasterkRH. 2004. Dicers at RISC; the mechanism of RNAi. Cell, 117:1–3.
AmbrosV. 2003. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell, 113:673–676.
32.
SuzukiT, HigginsPJ, CrawfordDR. 2000. Control selection for RNA quantitation. Biotechniques, 29:332–337.
33.
AmitM, WinklerME, MenkeS, BruningE, BuscherK, DennerJ, HaverichA, Itskovitz-EldorJ, MartinU. 2005. No evidence for infection of human embryonic stem cells by feeder cell-derived murine leukemia viruses. Stem Cells, 23:761–771.
34.
SdassiN, SilveriL, LaubierJ, TillyG, CostaJ, LayaniS, VilotteJL, Le ProvostF. 2009. Identification and characterization of new miRNAs cloned from normal mouse mammary gland. BMC Genomics, 10:149.
35.
BrodersenP, VoinnetO. 2009. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol, 10:141–148.
36.
PolisenoL, PittoL, SimiliM, MarianiL, RiccardiL, CiucciA, RizzoM, EvangelistaM, MercatantiA, PandolfiPP, RainaldiG. 2008. The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. PLoS One, 3:e2542.
37.
DoxakisE. 2010. Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem, 285:12726–12734.
38.
DoenchJG, SharpPA. 2004. Specificity of microRNA target selection in translational repression. Genes Dev, 18:504–511.
RudiniN, FeliciA, GiampietroC, LampugnaniM, CoradaM, SwirsdingK, GarreM, LiebnerS, LetarteM, ten DijkeP, DejanaE. 2008. VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J, 27:993–1004.
41.
VestweberD. 2008. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol, 28:223–232.
42.
LarsonJD, WadmanSA, ChenE, KerleyL, ClarkKJ, EideM, LippertS, NaseviciusA, EkkerSC, HackettPB, EssnerJJ. 2004. Expression of VE-cadherin in zebrafish embryos: a new tool to evaluate vascular development. Dev Dyn, 231:204–213.
43.
Gory-FaureS, PrandiniMH, PointuH, RoullotV, Pignot-PaintrandI, VernetM, HuberP. 1999. Role of vascular endothelial-cadherin in vascular morphogenesis. Development, 126:2093–2102.
44.
LebrinF, GoumansMJ, JonkerL, CarvalhoRL, ValdimarsdottirG, ThorikayM, MummeryC, ArthurHM, ten DijkeP. 2004. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J, 23:4018–4028.
45.
DallasNA, SamuelS, XiaL, FanF, GrayMJ, LimSJ, EllisLM. 2008. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res, 14:1931–1937.
46.
ArthurHM, UreJ, SmithAJ, RenforthG, WilsonDI, TorsneyE, CharltonR, ParumsDV, JowettTet al.2000. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol, 217:42–53.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
